Lemzoparlimab is a monoclonal antibody commercialized by I-Mab, with a leading P...
(Clesacostat tromethamine + Ervogastat) is a small molecule commercialized by Pf...
Imlunestrant tosylate is a small molecule commercialized by Eli Lilly and Co, wi...
ADI-001 is a gene-modified cell therapy commercialized by Adicet Bio, with a lea...
Rapcabtagene autoleucel is a gene-modified cell therapy commercialized by Novart...
Public health experts are anticipating a changing discourse following RFK Jr’s a...
AIM ImmunoTech has secured a patent from the Netherlands Patent Office for Ampli...
RLYB-116 is a fusion protein commercialized by Rallybio, with a leading Phase I ...
ORIC-944 is a small molecule commercialized by ORIC Pharmaceuticals, with a lead...
Rhenium (186Re) Obisbemeda is a small molecule commercialized by Plus Therapeuti...
As part of a first-line treatment for patients with inoperable pancreatic adenoc...
Novartis has paid out $1 billion upfront for worldwide rights to PTC Therapeutic...
The results from the Phase III trial found the LDL-C treatment to be well tolera...
The EMA has validated Chiesi Global Rare Diseases and Protalix’s submission to u...
An improved price discount and new evidence from Santhera has changed NICE’s tun...
The respiratory syncytial virus (RSV) prophylaxis market across the eight major ...
